BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Capote-Moreno A, Ramos E, Egea J, López-Muñoz F, Gil-Martín E, Romero A. Potential of Melatonin as Adjuvant Therapy of Oral Cancer in the Era of Epigenomics. Cancers (Basel) 2019;11:E1712. [PMID: 31684096 DOI: 10.3390/cancers11111712] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Su SC, Yeh CM, Lin CW, Hsieh YH, Chuang CY, Tang CH, Lee YC, Yang SF. A novel melatonin-regulated lncRNA suppresses TPA-induced oral cancer cell motility through replenishing PRUNE2 expression. J Pineal Res 2021;:e12760. [PMID: 34339541 DOI: 10.1111/jpi.12760] [Reference Citation Analysis]
2 Novais AA, Chuffa LGA, Zuccari DAPC, Reiter RJ. Exosomes and Melatonin: Where Their Destinies Intersect. Front Immunol 2021;12:692022. [PMID: 34177952 DOI: 10.3389/fimmu.2021.692022] [Reference Citation Analysis]
3 Wang S, Wei M, Zhu W. WITHDRAWN: Melatonin increases doxorubicin-induced apoptosis via oxidative DNA damage in oral squamous cell carcinoma. DNA Repair 2021. [DOI: 10.1016/j.dnarep.2021.103154] [Reference Citation Analysis]
4 Lang L, Xiong Y, Prieto-Dominguez N, Loveless R, Jensen C, Shay C, Teng Y. FGF19/FGFR4 signaling axis confines and switches the role of melatonin in head and neck cancer metastasis. J Exp Clin Cancer Res 2021;40:93. [PMID: 33691750 DOI: 10.1186/s13046-021-01888-9] [Reference Citation Analysis]
5 Mu Q, Najafi M. Modulation of the tumor microenvironment (TME) by melatonin. Eur J Pharmacol 2021;907:174365. [PMID: 34302814 DOI: 10.1016/j.ejphar.2021.174365] [Reference Citation Analysis]
6 Egea J, López-Muñoz F, Fernández-Capetillo O, Reiter RJ, Romero A. Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies. Front Pharmacol 2022;13:873197. [PMID: 35401215 DOI: 10.3389/fphar.2022.873197] [Reference Citation Analysis]
7 Pourhanifeh MH, Mehrzadi S, Kamali M, Hosseinzadeh A. Melatonin and gastrointestinal cancers: Current evidence based on underlying signaling pathways. Eur J Pharmacol 2020;886:173471. [PMID: 32877658 DOI: 10.1016/j.ejphar.2020.173471] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
8 Ma WY, Song RJ, Xu BB, Xu Y, Wang XX, Sun HY, Li SN, Liu SZ, Yu MX, Yang F, Ye DY, Gong R, Han ZB, Yu Y, Bamba D, Wang N, Pan ZW, Cai BZ. Melatonin promotes cardiomyocyte proliferation and heart repair in mice with myocardial infarction via miR-143-3p/Yap/Ctnnd1 signaling pathway. Acta Pharmacol Sin 2021;42:921-31. [PMID: 32839503 DOI: 10.1038/s41401-020-0495-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 14.0] [Reference Citation Analysis]
9 Pourhanifeh MH, Mehrzadi S, Hosseinzadeh A. Melatonin and regulation of miRNAs: novel targeted therapy for cancerous and noncancerous disease. Epigenomics 2021;13:65-81. [PMID: 33350862 DOI: 10.2217/epi-2020-0241] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
10 Fang Y, Yang C, Yu Z, Li X, Mu Q, Liao G, Yu B. Natural products as LSD1 inhibitors for cancer therapy. Acta Pharm Sin B 2020. [PMID: 32837872 DOI: 10.1016/j.apsb.2020.06.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 12.5] [Reference Citation Analysis]
11 Bjørklund G, Rajib SA, Saffoon N, Pen JJ, Chirumbolo S. Insights on Melatonin as an Active Pharmacological Molecule in Cancer Prevention: What's New? Curr Med Chem 2019;26:6304-20. [PMID: 29714136 DOI: 10.2174/0929867325666180501094850] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
12 Shih YH, Chiu KC, Wang TH, Lan WC, Tsai BH, Wu LJ, Hsia SM, Shieh TM. Effects of melatonin to arecoline-induced reactive oxygen species production and DNA damage in oral squamous cell carcinoma. J Formos Med Assoc 2021;120:668-78. [PMID: 32800657 DOI: 10.1016/j.jfma.2020.07.037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 El-Missiry MA, El-Missiry ZMA, Othman AI. Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19. Eur J Pharmacol 2020;882:173329. [PMID: 32615182 DOI: 10.1016/j.ejphar.2020.173329] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
14 Ramos E, López-Muñoz F, Gil-Martín E, Egea J, Álvarez-Merz I, Painuli S, Semwal P, Martins N, Hernández-Guijo JM, Romero A. The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy. Antioxidants (Basel) 2021;10:1152. [PMID: 34356384 DOI: 10.3390/antiox10071152] [Cited by in F6Publishing: 1] [Reference Citation Analysis]